4//SEC Filing
CAIN CHRISTOPHER W. 4
Accession 0000950170-25-062102
CIK 0001798749other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:07 PM ET
Size
6.2 KB
Accession
0000950170-25-062102
Insider Transaction Report
Form 4
CAIN CHRISTOPHER W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-29+23,017→ 23,017 totalExercise: $10.14Exp: 2035-04-29→ Common Stock (23,017 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer.
- [F2]Under the Reporting Person's arrangement with Fairmount Funds Management LLC ("Fairmount"), the Reporting Person holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.
Documents
Issuer
Jade Biosciences, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001817733
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:07 PM ET
- Size
- 6.2 KB